Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease

Johns Hopkins University, Baltimore, Maryland, United States
Neurology (Impact Factor: 8.3). 02/2007; 68(1):13-9. DOI: 10.1212/01.wnl.0000250326.77323.01
Source: PubMed

ABSTRACT Neuroimaging in mild cognitive impairment (MCI) and Alzheimer disease (AD) generally shows medial temporal lobe atrophy and diminished glucose metabolism and cerebral blood flow in the posterior cingulate gyrus. However, it is unclear whether these abnormalities also impact the cingulum fibers, which connect the medial temporal lobe and the posterior cingulate regions.
To use diffusion tensor imaging (DTI), by measuring fractional anisotropy (FA), to test 1) if MCI and AD are associated with DTI abnormalities in the parahippocampal and posterior cingulate regions of the cingulum fibers; 2) if white matter abnormalities extend to the neocortical fiber connections in the corpus callosum (CC); 3) if DTI improves accuracy to separate AD and MCI from healthy aging vs structural MRI.
DTI and structural MRI were preformed on 17 patients with AD, 17 with MCI, and 18 cognitively normal (CN) subjects.
FA of the cingulum fibers was significantly reduced in MCI, and even more in AD. FA was also significantly reduced in the splenium of the CC in AD, but not in MCI. Adding DTI to hippocampal volume significantly improved the accuracy to separate MCI and AD from CN.
Assessment of the cingulum fibers using diffusion tensor imaging may aid early diagnosis of Alzheimer disease.


Available from: Susanne G Mueller, May 05, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The posterior cingulate cortex (PCC) is the brain region displaying the earliest sign of energy hypometabolism in patients with amnestic mild cognitive impairment (MCI) who develop Alzheimer's disease (AD). In particular, the activity of the mitochondrial respiratory enzyme cytochrome oxidase (C.O.) is selectively inhibited within the PCC in AD. The present study is the first experimental analysis designed to model in animals the localized cortical C.O. inhibition found as the earliest metabolic sign of early-stage AD in human neuroimaging studies. Rats were used to model local inhibition of C.O. by direct injection of the C.O. inhibitor sodium azide into the PCC. Learning and memory were examined in a spatial holeboard task and brains were analyzed using quantitative histochemical, morphological and biochemical techniques. Behavioral results showed that sodium azide-treated rats were impaired in their memory of the baited pattern in probe trials as compared to their training scores before treatment, without non-specific behavioral differences. Brain analyses showed that C.O. inhibition was specific to the PCC, and sodium azide increased lipid peroxidation, gliosis and neuron loss, and lead to a network functional disconnection between the PCC and interconnected hippocampal regions. It was concluded that impaired memory by local C.O. inhibition in the PCC may serve to model in animals a metabolic lesion similar to that found in patients with amnestic MCI and early-stage AD. This model may be useful as an in vivo testing platform to investigate neuroprotective strategies to prevent or reduce the amnestic effects produced by posterior cingulate energy hypometabolism.
    Neurobiology of Learning and Memory 08/2008; 90(1):112-24. DOI:10.1016/j.nlm.2008.01.011 · 4.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This synthetic review presents an approach to the use of biomarkers for the development of new treatments for Alzheimer's disease (AD). After reviewing the process of translation as applied to AD, the paper provides a general update on what is known about the biology of the disease, and highlights currently available treatments. This is followed by a discussion of future drug development for AD emphasizing the roles that biomarkers are likely to play in this process: (1) define patients who are going to progress rapidly for the purpose of trial enrichment; (2) differentiate disease and therapeutically relevant AD subtypes; (3) assess the potential activity of specific therapies in vivo or ex vivo; and (4) measure the underlying disease state, so as to (a) detect disease and assess drug response in asymptomatic patients, (b) serve as a secondary outcome measure in clinical trials of symptomatic patients, and (c) decide if further development of a treatment should be stopped if not likely to be effective. Several examples are used to illustrate each biomarker utility in the AD context.
    International Psychogeriatrics 06/2008; 20(5):871-89. DOI:10.1017/S1041610208007382 · 1.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies were carried out to detect brain tissue damage in patients with vascular cognitive impairment (VCI) using diffusion tensor imaging (DTI) histogram analysis, and to determine the correlations between DTI histogram-derived measures and Mini-Mental State Examination (MMSE) scores. Conventional MRI and DTI scans were performed on 19 patients with VCI, 19 age- and sex-matched post-stroke patients without cognitive impairment (stroke group) and 19 cognitively normal subjects (CN group). Histograms of the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) of the whole brain were analyzed. Analysis showed that the patterns of the whole brain ADC and FA histograms of the VCI group differed from those of the stroke and CN groups. Compared with those of the two control groups, the mean FA value was significantly lower and the FA histogram peak height was higher in the VCI group. However, the patterns of the whole brain ADC and FA histograms in the stroke group were similar to those of the CN group, and there were no significant differences in any of the DTI histogram-derived measures between these two groups. The mean FA value, the FA histogram peak height, and the FA histogram peak location in VCI patients correlated with the MMSE scores. Our findings suggest that VCI leads to abnormal diffusion in brain tissue, and that DTI histogram-derived measures might be used to monitor the severity of cognitive impairment in this disease.
    Journal of the Neurological Sciences 06/2008; 268(1-2):60-4. DOI:10.1016/j.jns.2007.11.005 · 2.26 Impact Factor